Alan D. Horsager
Vorstandsvorsitzender bei Olimmune, Inc.
Aktive Positionen von Alan D. Horsager
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Olimmune, Inc.
Olimmune, Inc. Pharmaceuticals: MajorHealth Technology Part of Scopus Biopharma, Inc., Olimmune, Inc. develops immunotherapies for cancer treatment. The private company is based in Glendale, CA. The company was founded by Marcin Kortylewski. The CEO is Alan D. Horsager. Olimmune was acquired by Scopus Biopharma, Inc. on June 30, 2021. | Vorstandsvorsitzender | - | - |
Präsident | - | - | |
Duet BioTherapeutics, Inc.
Duet BioTherapeutics, Inc. BiotechnologyHealth Technology Part of Scopus Biopharma, Inc., Duet BioTherapeutics, Inc. is a biotechnology company based in Pasadena, CA. The private company develops novel immunotherapies to overcome treatment-resistant cancers by selectively and simultaneously activating TLR9, which stimulates the body's immune system, and inhibiting STAT3, which counteracts critical tumor defense mechanisms. Duet is pursuing therapeutic candidates for the treatment of solid tumors and hematological malignancies using a distinct set of oligonucleotide inhibitors, including antisense, small-interfering RNA, and decoy technologies. Duet-101, the company's IND-ready lead candidate, combines CPG with a STAT3-inhibiting ASO and is being developed for the treatment of advanced solid tumors. The CEO of the company is Alan D. Horsager. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | - | - | |
Präsident | - | - |
Karriereverlauf von Alan D. Horsager
Ehemalige bekannte Positionen von Alan D. Horsager
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SCOPUS BIOPHARMA INC. | Präsident | 12.07.2021 | - |
Ausbildung von Alan D. Horsager
University of Washington | Undergraduate Degree |
University of Southern California | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
President | 3 |
Chief Executive Officer | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SCOPUS BIOPHARMA INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Olimmune, Inc.
Olimmune, Inc. Pharmaceuticals: MajorHealth Technology Part of Scopus Biopharma, Inc., Olimmune, Inc. develops immunotherapies for cancer treatment. The private company is based in Glendale, CA. The company was founded by Marcin Kortylewski. The CEO is Alan D. Horsager. Olimmune was acquired by Scopus Biopharma, Inc. on June 30, 2021. | Health Technology |
Duet BioTherapeutics, Inc.
Duet BioTherapeutics, Inc. BiotechnologyHealth Technology Part of Scopus Biopharma, Inc., Duet BioTherapeutics, Inc. is a biotechnology company based in Pasadena, CA. The private company develops novel immunotherapies to overcome treatment-resistant cancers by selectively and simultaneously activating TLR9, which stimulates the body's immune system, and inhibiting STAT3, which counteracts critical tumor defense mechanisms. Duet is pursuing therapeutic candidates for the treatment of solid tumors and hematological malignancies using a distinct set of oligonucleotide inhibitors, including antisense, small-interfering RNA, and decoy technologies. Duet-101, the company's IND-ready lead candidate, combines CPG with a STAT3-inhibiting ASO and is being developed for the treatment of advanced solid tumors. The CEO of the company is Alan D. Horsager. | Health Technology |
- Börse
- Insiders
- Alan D. Horsager
- Erfahrung